DE60335608D1 - Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung - Google Patents
Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendungInfo
- Publication number
- DE60335608D1 DE60335608D1 DE60335608T DE60335608T DE60335608D1 DE 60335608 D1 DE60335608 D1 DE 60335608D1 DE 60335608 T DE60335608 T DE 60335608T DE 60335608 T DE60335608 T DE 60335608T DE 60335608 D1 DE60335608 D1 DE 60335608D1
- Authority
- DE
- Germany
- Prior art keywords
- compositions
- therapeutics
- delivery
- materials
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 239000000463 material Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000002184 metal Substances 0.000 abstract 2
- 239000013543 active substance Substances 0.000 abstract 1
- 229910021645 metal ion Inorganic materials 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36035002P | 2002-02-27 | 2002-02-27 | |
| PCT/US2003/005937 WO2003072143A1 (en) | 2002-02-27 | 2003-02-27 | Compositions for delivery of therapeutics and other materials, and methods of making and using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60335608D1 true DE60335608D1 (de) | 2011-02-17 |
Family
ID=27766225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60335608T Expired - Lifetime DE60335608D1 (de) | 2002-02-27 | 2003-02-27 | Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7138105B2 (de) |
| EP (1) | EP1478406B1 (de) |
| JP (1) | JP2005524657A (de) |
| AT (1) | ATE494010T1 (de) |
| AU (1) | AU2003219922B2 (de) |
| CA (1) | CA2476589C (de) |
| DE (1) | DE60335608D1 (de) |
| WO (1) | WO2003072143A1 (de) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040220100A1 (en) * | 2000-07-21 | 2004-11-04 | Essentia Biosystems, Inc. | Multi-component biological transport systems |
| US20030194798A1 (en) * | 2001-05-24 | 2003-10-16 | Surber Mark W. | Minicell compositions and methods |
| JP4360917B2 (ja) * | 2002-02-26 | 2009-11-11 | 株式会社バイオメッドコア | リポソームへの金属錯体の封入方法 |
| US7635463B2 (en) * | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
| DE60335608D1 (de) * | 2002-02-27 | 2011-02-17 | Pharmain Corp | Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung |
| US20050260259A1 (en) * | 2004-04-23 | 2005-11-24 | Bolotin Elijah M | Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| US20100069293A1 (en) * | 2002-02-27 | 2010-03-18 | Pharmain Corporation | Polymeric carrier compositions for delivery of active agents, methods of making and using the same |
| US7629049B2 (en) * | 2002-10-18 | 2009-12-08 | Medasorb, Inc. | Hemocompatible polymer systems and related devices |
| EP1659143A4 (de) * | 2003-07-28 | 2008-10-08 | Teijin Ltd | Auf temperatur ansprechendes hydrogel |
| WO2005012364A2 (fr) * | 2003-07-30 | 2005-02-10 | Anteis S.A. | Matrice complexe a usage biomedical |
| ATE365034T1 (de) * | 2003-09-10 | 2007-07-15 | Cristalia Prod Quimicos Farm | Stabile pharmazeutische zusammensetzung einer fluorether-verbindung für die anästhesie, verfahren zur stabilisierung einer fluorether- verbindung, verwendung eines stabilisierungsmittels zum ausschluss des abbaus einer fluorether-verbindung |
| AU2005215846B2 (en) * | 2004-02-23 | 2011-01-27 | Caiteng Zhang | A solution of metal-polymer chelate(s) and applications thereof |
| US9211248B2 (en) | 2004-03-03 | 2015-12-15 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| US8092788B2 (en) | 2004-03-03 | 2012-01-10 | Revance Therapeutics, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
| CN1946431B (zh) * | 2004-03-03 | 2011-12-07 | 雷文斯治疗公司 | 用于肉毒毒素的局部施用和透皮递送的组合物和方法 |
| BRPI0404983A (pt) * | 2004-09-03 | 2006-05-02 | Nanocore Biotecnologia Ltda | composições imunogênicas |
| AU2006204045B2 (en) * | 2005-01-05 | 2010-10-14 | Board Of Regents, The University Of Texas System | Conjugates for dual imaging and radiochemotherapy: composition, manufacturing, and applications |
| US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
| US20090291508A1 (en) * | 2008-05-20 | 2009-11-26 | Rapid Pathogen Screening Inc. | Nanoparticles in diagnostic tests |
| US9314416B2 (en) * | 2005-03-03 | 2016-04-19 | Revance Therapeutics, Inc. | Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| DE502006007526D1 (de) * | 2005-09-09 | 2010-09-09 | Aesculap Ag | Antimikrobielles medizintechnisches produkt, verfahren zu seiner herstellung und verwendung |
| JP4670583B2 (ja) * | 2005-10-20 | 2011-04-13 | チッソ株式会社 | 水溶性カチオン性磁気微粒子を用いた脂質ベシクルの分離又は検出方法 |
| WO2007064945A2 (en) | 2005-12-01 | 2007-06-07 | Pronai Therapeutics, Inc. | Cancer therapies and pharmaceutical compositions used therein |
| KR101872061B1 (ko) * | 2005-12-19 | 2018-06-27 | 파마인 코포레이션 | 치료제를 전달하기 위한 소수성 코어 담체 조성물, 이 조성물의 제조 방법 및 그 조성물의 이용 방법 |
| ES2422864T3 (es) | 2006-08-09 | 2013-09-16 | Intarcia Therapeutics, Inc | Sistemas de liberación osmótica y unidades de pistón |
| US9604196B2 (en) | 2006-11-20 | 2017-03-28 | Cytosorbent, Inc. | Size-selective hemocompatible polymer system |
| JP2010510248A (ja) * | 2006-11-21 | 2010-04-02 | ビアメト ファーマシューティカルズ，インク． | 金属結合部分をターゲティング部分と組み合わせて使用する金属酸化還元酵素阻害剤 |
| US20090246155A1 (en) * | 2006-12-05 | 2009-10-01 | Landec Corporation | Compositions and methods for personal care |
| US20100004124A1 (en) * | 2006-12-05 | 2010-01-07 | David Taft | Systems and methods for delivery of materials for agriculture and aquaculture |
| US20090263346A1 (en) * | 2006-12-05 | 2009-10-22 | David Taft | Systems and methods for delivery of drugs |
| EP2101745A4 (de) * | 2006-12-05 | 2009-12-30 | Landec Corp | Abgabe von arzneimitteln |
| US8399007B2 (en) * | 2006-12-05 | 2013-03-19 | Landec Corporation | Method for formulating a controlled-release pharmaceutical formulation |
| WO2008128058A1 (en) * | 2007-04-13 | 2008-10-23 | The Trustees Of The University Of Pennsylvania | New gallium bisaminothiolate complexes for myocardial imaging |
| RU2440097C2 (ru) | 2007-04-23 | 2012-01-20 | Интарсия Терапьютикс, Инк. | Способ лечения диабета ii типа и ожирения, осмотическое устройство для доставки и способ его изготовления |
| US9364432B2 (en) | 2007-06-11 | 2016-06-14 | Edge Therapeutics, Inc. | Intraventricular drug delivery system for improving outcome after a brain injury affecting cerebral blood flow |
| US10092524B2 (en) | 2008-06-11 | 2018-10-09 | Edge Therapeutics, Inc. | Compositions and their use to treat complications of aneurysmal subarachnoid hemorrhage |
| US7960336B2 (en) | 2007-08-03 | 2011-06-14 | Pharmain Corporation | Composition for long-acting peptide analogs |
| US8563527B2 (en) | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
| US9095568B2 (en) * | 2007-09-26 | 2015-08-04 | Mark Berninger | Therapeutic and vaccine polyelectrolyte nanoparticle compositions |
| US8114883B2 (en) * | 2007-12-04 | 2012-02-14 | Landec Corporation | Polymer formulations for delivery of bioactive materials |
| US20090176892A1 (en) | 2008-01-09 | 2009-07-09 | Pharmain Corporation | Soluble Hydrophobic Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same |
| EP2240155B1 (de) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe |
| WO2009114520A2 (en) * | 2008-03-10 | 2009-09-17 | Pharmain Corporation | Compositions for treatment with metallopeptidases, methods of making and using the same |
| KR101760953B1 (ko) * | 2008-09-04 | 2017-07-24 | 아밀린 파마슈티칼스, 엘엘씨. | 비-수성 담체를 이용한 서방성 제형물 |
| JP5820378B2 (ja) * | 2009-09-09 | 2015-11-24 | ファーマイン コーポレーションＰｈａｒｍａｉｎ Ｃｏｒｐｏｒａｔｉｏｎ | 治療剤の送達のための陰イオンコア組成物およびその製造ならびに使用方法 |
| EP3323423B1 (de) | 2009-09-28 | 2020-06-17 | Intarcia Therapeutics, Inc | Schnelle initiierung und/oder beendigung der verabreichung substantiell stabiler arzneimittel |
| DK2343051T3 (da) | 2010-01-05 | 2014-10-27 | Nat Univ Dong Hwa | Anti-cancer formulering |
| NZ602000A (en) * | 2010-02-22 | 2015-05-29 | Edge Therapeutics Inc | Methods and compositions to treat hemorrhagic conditions of the brain |
| US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
| US8785569B2 (en) * | 2011-11-22 | 2014-07-22 | Original Biomedicals Co., Ltd. | Drug carrier with chelating complex micelles and the application thereof |
| WO2014071406A1 (en) | 2012-11-05 | 2014-05-08 | Pronai Therapeutics, Inc. | Methods of using biomarkers for the treatment of cancer by modulation of bcl2|expression |
| US20160303242A1 (en) | 2013-12-09 | 2016-10-20 | Durect Corporation | Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same |
| BR112017005382A2 (pt) | 2014-09-24 | 2018-07-31 | Colgate Palmolive Co | biodisponibilidade de íons metálicos |
| US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
| EP3302354B1 (de) | 2015-06-03 | 2023-10-04 | i2o Therapeutics, Inc. | Systeme zum einsetzen eines implantats |
| CN105054074A (zh) * | 2015-07-01 | 2015-11-18 | 浙江海洋学院 | 一种鱼糜酶解肽亚铁螯合物抗氧化微胶囊及其制备工艺 |
| JP6852079B2 (ja) * | 2015-10-09 | 2021-03-31 | デベデック フランツ レ | 架橋粒子 |
| WO2017200943A1 (en) | 2016-05-16 | 2017-11-23 | Intarcia Therapeutics, Inc. | Glucagon-receptor selective polypeptides and methods of use thereof |
| USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
| USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
| KR20190104039A (ko) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법 |
| US11905377B2 (en) | 2019-01-17 | 2024-02-20 | Pendant Biosciences, Inc. | Factors controlling drug release in cross-linked poly(valerolactone) based matrices |
| JP2022537331A (ja) * | 2019-06-18 | 2022-08-25 | マックス－プランク－ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | 金属錯体試薬を介するＨｉｓタグ付タンパク質などの標的分子への標識および／または担体の部位特異的、速度論的に不活性なコンジュゲーション |
Family Cites Families (115)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614492A (en) | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
| US5118666A (en) | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone |
| US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
| US5120712A (en) | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone |
| US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
| US5527524A (en) | 1986-08-18 | 1996-06-18 | The Dow Chemical Company | Dense star polymer conjugates |
| US4857311A (en) | 1987-07-31 | 1989-08-15 | Massachusetts Institute Of Technology | Polyanhydrides with improved hydrolytic degradation properties |
| US5681543A (en) | 1988-02-29 | 1997-10-28 | Shering Aktiengesellschaft | Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI |
| US5776894A (en) | 1988-12-05 | 1998-07-07 | Novartis Ag | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors |
| US5554388A (en) | 1989-02-25 | 1996-09-10 | Danbiosyst Uk Limited | Systemic drug delivery compositions comprising a polycationi substance |
| US5744166A (en) | 1989-02-25 | 1998-04-28 | Danbiosyst Uk Limited | Drug delivery compositions |
| US5542935A (en) | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
| JPH07503943A (ja) | 1991-10-29 | 1995-04-27 | クローバー コンソリデイテッド，リミテッド | 封入及び薬剤放出に有用な架橋性の多糖類、ポリカチオン及び脂質 |
| US5770563A (en) | 1991-12-06 | 1998-06-23 | The United States Of America As Represented By The Department Of Health And Human Services | Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof |
| DE69333434T2 (de) | 1992-04-03 | 2005-03-03 | The Regents Of The University Of California, Oakland | Selbstorganisierendes system zur verabreichung von polynukleotiden enthaltend ein amphiphatisches peptid |
| US6113946A (en) | 1992-04-03 | 2000-09-05 | The Regents Of The University Of California | Self-assembling polynucleotide delivery system comprising dendrimer polycations |
| DE69332952T2 (de) | 1992-09-04 | 2004-02-19 | The General Hospital Corp., Boston | Diagnostische und therapeutische Einheiten enthaltende biokompatible Polymere |
| US5871710A (en) * | 1992-09-04 | 1999-02-16 | The General Hospital Corporation | Graft co-polymer adducts of platinum (II) compounds |
| US5395619A (en) | 1993-03-03 | 1995-03-07 | Liposome Technology, Inc. | Lipid-polymer conjugates and liposomes |
| US6284727B1 (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
| US5605672A (en) | 1993-06-09 | 1997-02-25 | The General Hospital Corporation | Blood pool imaging composition and method of its use |
| US5763585A (en) | 1993-10-13 | 1998-06-09 | Anergen, Inc. | Method of making MHC-peptide complexes using metal chelate affinity chromatography |
| IL128775A (en) | 1994-03-07 | 2001-05-20 | Dow Chemical Co | A preparation containing a dendritic polymer in a complex with at least one unit of biological reaction sub |
| EP0804249A2 (de) | 1994-03-15 | 1997-11-05 | Brown University Research Foundation | Polymeres system zur freisetzung von genen |
| US5466467A (en) | 1994-03-30 | 1995-11-14 | The United States Of America As Represented By The Secretary Of The Navy | Liposomes containing polymerized lipids for non-covalent immobilization of proteins and enzymes |
| GB9409496D0 (en) | 1994-05-12 | 1994-06-29 | London Health Ass | Method for improving glycaemic control in diabetes |
| US20010006943A1 (en) | 1994-12-23 | 2001-07-05 | Ejvind Jensen | Protracted GLP-1 compositions |
| US5834428A (en) | 1995-04-14 | 1998-11-10 | 1149336 Ontario Inc. | Glucagon-like peptide-2 and its therapeutic use |
| US5929031A (en) | 1995-05-02 | 1999-07-27 | Baxter Biotech Technology Sarl | Storage stable hemoglobin solutions |
| US5855610A (en) | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
| US6521211B1 (en) | 1995-06-07 | 2003-02-18 | Bristol-Myers Squibb Medical Imaging, Inc. | Methods of imaging and treatment with targeted compositions |
| US5891418A (en) * | 1995-06-07 | 1999-04-06 | Rhomed Incorporated | Peptide-metal ion pharmaceutical constructs and applications |
| CA2224253A1 (en) | 1995-06-09 | 1996-12-27 | Martin J. Macphee | Chitin hydrogels, methods of their production and use |
| MY147327A (en) | 1995-06-29 | 2012-11-30 | Novartis Ag | Somatostatin peptides |
| US5942253A (en) | 1995-10-12 | 1999-08-24 | Immunex Corporation | Prolonged release of GM-CSF |
| EP0856026A1 (de) | 1995-10-19 | 1998-08-05 | Receptagen Corporation | Polyethylenglycolen mit diskreter länge |
| ATE314843T1 (de) * | 1996-03-12 | 2006-02-15 | Pg Txl Co Lp | Wasserlösliche paclitaxel-prodrogen |
| US6254854B1 (en) | 1996-05-24 | 2001-07-03 | The Penn Research Foundation | Porous particles for deep lung delivery |
| US6277819B1 (en) | 1996-08-30 | 2001-08-21 | Eli Lilly And Company | Use of GLP-1 or analogs in treatment of myocardial infarction |
| US7235627B2 (en) | 1996-08-30 | 2007-06-26 | Novo Nordisk A/S | Derivatives of GLP-1 analogs |
| US6006753A (en) | 1996-08-30 | 1999-12-28 | Eli Lilly And Company | Use of GLP-1 or analogs to abolish catabolic changes after surgery |
| UA65549C2 (uk) | 1996-11-05 | 2004-04-15 | Елі Ліллі Енд Компані | Спосіб регулювання ожиріння шляхом периферійного введення аналогів та похідних glp-1 (варіанти) та фармацевтична композиція |
| JPH10158195A (ja) | 1996-11-28 | 1998-06-16 | Res Inst For Prod Dev | 配位結合を利用した薬物−高分子複合体製剤の調製方法 |
| US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
| US6120751A (en) * | 1997-03-21 | 2000-09-19 | Imarx Pharmaceutical Corp. | Charged lipids and uses for the same |
| IL134084A0 (en) | 1997-07-18 | 2001-04-30 | Infimed Inc | Biodegradable macromers for the controlled release of biologically active substances |
| DE19740069A1 (de) * | 1997-09-12 | 1999-03-18 | Clariant Gmbh | Mischungen von langkettigen Phosphorsäurealkylestern |
| US6468532B1 (en) | 1998-01-22 | 2002-10-22 | Genentech, Inc. | Methods of treating inflammatory diseases with anti-IL-8 antibody fragment-polymer conjugates |
| US6703359B1 (en) | 1998-02-13 | 2004-03-09 | Amylin Pharmaceuticals, Inc. | Inotropic and diuretic effects of exendin and GLP-1 |
| US6998387B1 (en) | 1998-03-19 | 2006-02-14 | Amylin Pharmaceuticals, Inc. | Human appetite control by glucagon-like peptide receptor binding compounds |
| US6509323B1 (en) | 1998-07-01 | 2003-01-21 | California Institute Of Technology | Linear cyclodextrin copolymers |
| EP2028269B1 (de) | 1998-08-10 | 2015-10-21 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Differenzierung von nicht Insulin-produzierenden Zellen in Insulin-produzierende Zellen durch GLP-1 oder Exendin-4 und Verwendung |
| ES2284266T3 (es) | 1998-08-12 | 2007-11-01 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Composiciones terapeuticas liposomicas que se pueden obtener mediante el uso de un grandiente de sulfato amonico. |
| US6284725B1 (en) | 1998-10-08 | 2001-09-04 | Bionebraska, Inc. | Metabolic intervention with GLP-1 to improve the function of ischemic and reperfused tissue |
| CN1338924A (zh) * | 1999-01-08 | 2002-03-06 | 艾米斯菲尔技术有限公司 | 聚合物输送剂和输送剂化合物 |
| US6365173B1 (en) | 1999-01-14 | 2002-04-02 | Efrat Biopolymers Ltd. | Stereocomplex polymeric carriers for drug delivery |
| JP4812167B2 (ja) | 1999-02-12 | 2011-11-09 | モレキュラー インサイト ファーマスーティカルズ インコーポレイテッド | 薬物輸送用マトリックス、ならびにその作成方法および使用方法 |
| ATE419528T1 (de) | 1999-04-28 | 2009-01-15 | Eidgenoess Tech Hochschule | Polyionische beschichtungen für analytische und sensor-vorrichtungen |
| EP1223947A4 (de) * | 1999-10-15 | 2004-12-08 | Canji Inc | Zielgerichtete vektoren |
| US6569832B1 (en) | 1999-11-12 | 2003-05-27 | Novo Nordisk A/S | Inhibition of beta cell degeneration |
| US6593308B2 (en) * | 1999-12-03 | 2003-07-15 | The Regents Of The University Of California | Targeted drug delivery with a hyaluronan ligand |
| MXPA02009031A (es) | 2000-03-14 | 2004-08-19 | Amylin Pharmaceuticals Inc | Efectos del peptido-1(7-36) tipo glucagon en la motilidad antro-piloro.duodenal. |
| US6998137B2 (en) | 2000-04-07 | 2006-02-14 | Macromed, Inc. | Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| US6589549B2 (en) | 2000-04-27 | 2003-07-08 | Macromed, Incorporated | Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles |
| ES2290142T3 (es) | 2000-05-16 | 2008-02-16 | Bolder Biotechnology, Inc. | Metodos para replegamiento de proteinas que contiene residuos de cisteina libre. |
| AU6323001A (en) | 2000-05-19 | 2001-12-03 | Bionebraska Inc | Treatment of acute coronary syndrome with glp-1 |
| US6338859B1 (en) | 2000-06-29 | 2002-01-15 | Labopharm Inc. | Polymeric micelle compositions |
| EP1301213B1 (de) | 2000-07-21 | 2017-01-18 | ReVance Therapeutics, Inc. | Mehrkomponentensysteme zur transport von biologischen wirkstoffen |
| US20040092432A1 (en) | 2000-08-24 | 2004-05-13 | Thomas Jefferson University | Peptide compositions with effects on cerebral health |
| US6521736B2 (en) | 2000-09-15 | 2003-02-18 | University Of Massachusetts | Amphiphilic polymeric materials |
| AU775663B2 (en) | 2000-10-20 | 2004-08-12 | Amylin Pharmaceuticals, Inc. | Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 peptide |
| US20020132254A1 (en) * | 2000-11-30 | 2002-09-19 | Twu Jesse J. | Molecular labeling and assay systems using poly (amino acid)-metal ion complexes as linkers |
| WO2002048192A2 (en) | 2000-12-13 | 2002-06-20 | Eli Lilly And Company | Amidated glucagon-like peptide-1 |
| CA2431173A1 (en) | 2000-12-13 | 2002-06-20 | Eli Lilly And Company | Chronic treatment regimen using glucagon-like insulinotropic peptides |
| ITMI20011057A1 (it) | 2001-05-22 | 2002-11-22 | Bracco Imaging Spa | Preparazione ed uso di peptidi ciclici e ramificati e loro deriati marcati come agenti terapeutici agonisti o antagonisti della colecistochi |
| US7144863B2 (en) | 2001-06-01 | 2006-12-05 | Eli Lilly And Company | GLP-1 formulations with protracted time action |
| ES2298378T3 (es) | 2001-06-28 | 2008-05-16 | Novo Nordisk A/S | Formulacion estable de glp-1 modificado. |
| US6586524B2 (en) | 2001-07-19 | 2003-07-01 | Expression Genetics, Inc. | Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier |
| US7101843B2 (en) | 2001-08-23 | 2006-09-05 | Eli Lilly And Company | Glucagon-like peptide-1 analogs |
| CA2462543A1 (en) | 2001-10-01 | 2003-04-10 | Eli Lilly And Company | Glucagon-like peptides (glp-1) and treatment of respiratory distress |
| US7041646B2 (en) | 2001-10-05 | 2006-05-09 | Bayer Pharmaceuticals Corporation | Methods of treating type 2 diabetes with peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists |
| CN1596120A (zh) | 2001-11-26 | 2005-03-16 | 第一三得利制药株式会社 | 经鼻吸收用药物组合物 |
| EP2409569B1 (de) | 2002-02-20 | 2017-08-16 | Emisphere Technologies, Inc. | Verfahren zur Verabreichung von GLP1-Molekülen |
| DE60335608D1 (de) | 2002-02-27 | 2011-02-17 | Pharmain Corp | Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung |
| US20050260259A1 (en) | 2004-04-23 | 2005-11-24 | Bolotin Elijah M | Compositions for treatment with glucagon-like peptide, and methods of making and using the same |
| US7635463B2 (en) | 2002-02-27 | 2009-12-22 | Pharmain Corporation | Compositions for delivery of therapeutics and other materials |
| EP2028192A1 (de) | 2002-07-04 | 2009-02-25 | Zealand Pharma A/S | GLP-1 und Verfahren zur Diabetesbehandlung |
| JP2006501820A (ja) | 2002-09-06 | 2006-01-19 | バイエル・フアーマシユーチカルズ・コーポレーシヨン | 修飾ｇｌｐ−１受容体アゴニストおよびそれらの薬理学的使用法 |
| US20040209803A1 (en) | 2002-12-19 | 2004-10-21 | Alain Baron | Compositions for the treatment and prevention of nephropathy |
| US7790681B2 (en) | 2002-12-17 | 2010-09-07 | Amylin Pharmaceuticals, Inc. | Treatment of cardiac arrhythmias with GLP-1 receptor ligands |
| KR20060002922A (ko) | 2003-03-31 | 2006-01-09 | 알자 코포레이션 | 비수성 단일 상 비히클 및 이러한 비히클을 이용한 제형 |
| EP1631308B1 (de) | 2003-05-30 | 2013-07-31 | Amylin Pharmaceuticals, LLC | Neue verfahren und zusammensetzungen für die verbesserte transmukosale abgabe von peptiden und proteinen |
| JP4936884B2 (ja) | 2003-06-03 | 2012-05-23 | ノボ・ノルデイスク・エー／エス | 安定化された薬学的ペプチド組成物 |
| CN1812808B (zh) | 2003-06-03 | 2012-07-04 | 诺沃挪第克公司 | 稳定化的药物肽组合物 |
| US20060247167A1 (en) | 2003-09-01 | 2006-11-02 | Novo Nordisk A/S | Stable formulations of peptides |
| AR047776A1 (es) | 2003-12-16 | 2006-02-22 | Sod Conseils Rech Applic | Composiciones farmaceuticas glp - 1 |
| US20060286129A1 (en) | 2003-12-19 | 2006-12-21 | Emisphere Technologies, Inc. | Oral GLP-1 formulations |
| US8372966B2 (en) | 2003-12-19 | 2013-02-12 | University Of Cincinnati | Oligonucleotide decoys and methods of use |
| US20050143303A1 (en) | 2003-12-26 | 2005-06-30 | Nastech Pharmaceutical Company Inc. | Intranasal administration of glucose-regulating peptides |
| US20060074025A1 (en) | 2003-12-26 | 2006-04-06 | Nastech Pharmaceutical Company Inc. | Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability |
| US8092788B2 (en) | 2004-03-03 | 2012-01-10 | Revance Therapeutics, Inc. | Compositions and methods for topical diagnostic and therapeutic transport |
| FR2867679B1 (fr) | 2004-03-17 | 2008-08-22 | Oreal | Composition cosmetiques comprenant des polyamines modifiees et utilisations desdites compositions. |
| US7985424B2 (en) | 2004-04-20 | 2011-07-26 | Dendritic Nanotechnologies Inc. | Dendritic polymers with enhanced amplification and interior functionality |
| JP4510881B2 (ja) | 2004-04-20 | 2010-07-28 | デンドリティック ナノテクノロジーズ，インコーポレイテッド | 強化された拡大性と内部官能基性をもった樹枝状ポリマー |
| US7534449B2 (en) | 2004-07-01 | 2009-05-19 | Yale University | Targeted and high density drug loaded polymeric materials |
| WO2006014425A1 (en) | 2004-07-02 | 2006-02-09 | Biovalve Technologies, Inc. | Methods and devices for delivering glp-1 and uses thereof |
| ES2618028T3 (es) | 2004-07-19 | 2017-06-20 | Biocon Limited | Conjugados insulina-oligómero, formulaciones y usos de éstos. |
| US7285529B2 (en) | 2005-02-28 | 2007-10-23 | Gene Tools, Llc | Embedder compositions and methods for detecting and killing cells in acidic areas of tumors |
| US20090202497A1 (en) | 2005-08-23 | 2009-08-13 | The General Hospital Corporation | Use of glp-1, glp-1 derivatives or glp-1 fragments for skin regeneration, stimulation of hair growth, or treatment of diabetes |
| WO2007030706A1 (en) | 2005-09-08 | 2007-03-15 | New England Medical Center Hospitals, Inc. | Fragments of the glucagon-like peptide-i and uses thereof |
| CA2626865C (en) | 2005-10-25 | 2014-12-30 | Starpharma Pty Limited | Macromolecular compounds having controlled stoichiometry |
| ES2586236T3 (es) | 2005-11-04 | 2016-10-13 | Glaxosmithkline Llc | Procedimientos para administrar agentes hipoglucémicos |
| KR101872061B1 (ko) | 2005-12-19 | 2018-06-27 | 파마인 코포레이션 | 치료제를 전달하기 위한 소수성 코어 담체 조성물, 이 조성물의 제조 방법 및 그 조성물의 이용 방법 |
| US8337823B2 (en) | 2006-01-20 | 2012-12-25 | Starpharma Pty Limited | Modified macromolecule |
| US8563527B2 (en) | 2007-08-20 | 2013-10-22 | Pharmain Corporation | Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same |
-
2003
- 2003-02-27 DE DE60335608T patent/DE60335608D1/de not_active Expired - Lifetime
- 2003-02-27 EP EP03716207A patent/EP1478406B1/de not_active Expired - Lifetime
- 2003-02-27 US US10/378,100 patent/US7138105B2/en not_active Expired - Lifetime
- 2003-02-27 AU AU2003219922A patent/AU2003219922B2/en not_active Expired
- 2003-02-27 CA CA2476589A patent/CA2476589C/en not_active Expired - Lifetime
- 2003-02-27 AT AT03716207T patent/ATE494010T1/de not_active IP Right Cessation
- 2003-02-27 WO PCT/US2003/005937 patent/WO2003072143A1/en active Application Filing
- 2003-02-27 JP JP2003570887A patent/JP2005524657A/ja active Pending
-
2006
- 2006-07-05 US US11/428,803 patent/US7790140B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003219922B2 (en) | 2009-09-10 |
| EP1478406A4 (de) | 2006-01-11 |
| US20030224974A1 (en) | 2003-12-04 |
| WO2003072143A1 (en) | 2003-09-04 |
| CA2476589C (en) | 2014-02-25 |
| US7790140B2 (en) | 2010-09-07 |
| US20060239924A1 (en) | 2006-10-26 |
| EP1478406B1 (de) | 2011-01-05 |
| US7138105B2 (en) | 2006-11-21 |
| AU2003219922A1 (en) | 2003-09-09 |
| EP1478406A1 (de) | 2004-11-24 |
| CA2476589A1 (en) | 2003-09-04 |
| JP2005524657A (ja) | 2005-08-18 |
| WO2003072143A9 (en) | 2004-03-04 |
| ATE494010T1 (de) | 2011-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60335608D1 (de) | Zusammensetzungen zur abgabe von therapeutika und anderen materialien und verfahren zu ihrer herstellung und verwendung | |
| DE60021729D1 (de) | Photosensibilisatoren enthaltende antimikrobielle zusammensetzung, gegenstände und verfahren zur verwendung | |
| DE60043229D1 (de) | Zusammensetzung zur gefässbeschichtung | |
| ATE547101T1 (de) | Verfahren zur verwendung von diketopiperazinen und zusammensetzungen, die diese enthalten | |
| DE69933945D1 (de) | Polymer, verfahren zu seiner herstellung und zusammensetzung | |
| DE602004031134D1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| DE60314865D1 (de) | Verfahren zur herstellung von modifiziertem polymer, danach erhaltenes modifiziertes polymer und kautschukzusammensetzung | |
| ATE537826T1 (de) | Zusammensetzungen aus r(+)- und s(-)-pramipexol sowie verfahren zu ihrer anwendung | |
| DE60143635D1 (de) | Blockpolymer, Verfahren zur Herstellung von Polymer und Festpolymerelektrolytbrennstoffzelle | |
| UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
| DE50015883D1 (de) | Flächiges Implantat, Verfahren zu seiner Herstellung und Verwendung in der Chirurgie | |
| DE602004001956D1 (de) | Sehr dünner, hochkohlenstoffhaltiger Stahldraht und Verfahren zu dessen Herstellung | |
| ATE233762T1 (de) | Bicyclische polyamiosaure metallkomplexe, verfahren zu ihrer herstellung und ihre verwendung für medizinische bilderzeugung | |
| DE602004012796D1 (de) | Dichtungsprofil, Verfahren zu seiner Herstellung und Formwerkzeug zur Verwendung in diesem Verfahren | |
| DE69939475D1 (de) | Blockpolymerzusammensetzung, verfahren zu dessen herstellung und druckempfindliche klebstoffzusammensetzung | |
| ATE520781T1 (de) | Verfahren zur veränderung des gehalts von speicherstoffen in pflanzen | |
| DE602004015907D1 (de) | Konjugierte Dienamide, Verfahren zur deren Herstellung, diese enthaltende Zusammensetzungen sowie deren Verwendung | |
| DE60218524D1 (de) | Verfahren zur herstellung von wasserlöslichen methacrylpolymeren, wasserlösliche methacrylpolymere und deren verwendung | |
| DE502004012162D1 (de) | Elektrosterisch stabilisierte wässrige polyurethan-harze, verfahren zu ihrer herstellung und deren verwendung | |
| DE602005023468D1 (de) | Verwendung von zahnfleischfibroblasten zur behandlung von vaskulären zellen | |
| WO2007019550A3 (en) | Composition and method for use in cartilage affecting conditions | |
| ATA6302000A (de) | Haftmittel für zahnprothesen und verfahren zu seiner herstellung | |
| EP1624859A4 (de) | Verfahren zur herstellung von thermogeformten zusammensetzungen mit acrylpolymerbindemitteln, pharmazeutische dosierformen und verfahren zu ihrer herstellung | |
| DE602004020874D1 (de) | Zusammensetzungen enthaltend hohe konzentration von kontrastmittel zur embolisierung von blutgefassen | |
| ATE445235T1 (de) | Verfahren zur herstellung von zinkpulver- agglomeraten und diese enthaltenden artikel |